{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:04:44Z","timestamp":1791414284361,"version":"4.3.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T00:00:00Z","timestamp":1212451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/ncpendmet0844","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T17:10:37Z","timestamp":1212513037000},"page":"415-419","source":"Crossref","is-referenced-by-count":83,"title":["Treatment of male infertility secondary to morbid obesity"],"prefix":"10.1038","volume":"4","author":[{"given":"Mara Y","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"Amory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,3]]},"reference":[{"key":"BFncpendmet0844_CR1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2164\/jandrol.106.000125","volume":"27","author":"AO Hammoud","year":"2006","unstructured":"Hammoud AO  et al. (2006) Obesity and male reproductive potential. J Androl 27: 619\u2013626","journal-title":"J Androl"},{"key":"BFncpendmet0844_CR2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-5347(01)69099-2","volume":"167","author":"JD Raman","year":"2002","unstructured":"Raman JD and Schlegel PN (2002) Aromatase inhibitors for male infertility. J Urol 167: 624\u2013629","journal-title":"J Urol"},{"key":"BFncpendmet0844_CR3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.291.6510.1693","volume":"291","author":"MG Hull","year":"1985","unstructured":"Hull MG  et al. (1985) Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 291: 1693\u20131697","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BFncpendmet0844_CR4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.fertnstert.2004.03.056","volume":"82","author":"TK Jensen","year":"2004","unstructured":"Jensen TK  et al. (2004) Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 82: 863\u2013870","journal-title":"Fertil Steril"},{"key":"BFncpendmet0844_CR5","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.291.23.2847","volume":"291","author":"AA Hedley","year":"2004","unstructured":"Hedley AA  et al. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291: 2847\u20132850","journal-title":"JAMA"},{"key":"BFncpendmet0844_CR6","doi-asserted-by":"crossref","unstructured":"Aggerholm AS  et al. (2007) Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil Steril [doi:10.1016\/j.fertnstert.2007.07.1292]","DOI":"10.1016\/j.fertnstert.2007.07.1292"},{"key":"BFncpendmet0844_CR7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/01.ede.0000229953.76862.e5","volume":"17","author":"M Sallmen","year":"2006","unstructured":"Sallmen M  et al. (2006) Reduced fertility among overweight and obese men. Epidemiology 17: 520\u2013523","journal-title":"Epidemiology"},{"key":"BFncpendmet0844_CR8","doi-asserted-by":"crossref","unstructured":"Hammoud AO  et al. (2008) Male obesity and alteration in sperm parameters. Fertil Steril. [doi:10.1016\/j.fertnstert.2007.10.011]","DOI":"10.1016\/j.fertnstert.2007.10.011"},{"key":"BFncpendmet0844_CR9","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/humrep\/dem139","volume":"22","author":"RH Nguyen","year":"2007","unstructured":"Nguyen RH  et al. (2007) Men's body mass index and infertility. Hum Reprod 22: 2488\u20132493","journal-title":"Hum Reprod"},{"key":"BFncpendmet0844_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/01485010500315479","volume":"52","author":"I Fejes","year":"2006","unstructured":"Fejes I  et al. (2006) Effect of body weight on testosterone\/estradiol ratio in oligozoospermic patients. Arch Androl 52: 97\u2013102","journal-title":"Arch Androl"},{"key":"BFncpendmet0844_CR11","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/jc.2006-0462","volume":"91","author":"G Raven","year":"2006","unstructured":"Raven G  et al. (2006) In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metab 91: 3324\u20133328","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0844_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2007.10.020","volume":"388","author":"PM Sluss","year":"2008","unstructured":"Sluss PM  et al. (2008) Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect(R). Clin Chim Acta 388: 99\u2013105","journal-title":"Clin Chim Acta"},{"key":"BFncpendmet0844_CR13","first-page":"2670","volume":"85","author":"PJ Snyder","year":"2000","unstructured":"Snyder PJ  et al. (2000) Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85: 2670\u20132677","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0844_CR14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","volume":"91","author":"S Bhasin","year":"2006","unstructured":"Bhasin S  et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995\u20132010","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0844_CR15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0026-0495(03)00186-0","volume":"52","author":"B Zumoff","year":"2003","unstructured":"Zumoff B  et al. (2003) Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism 52: 1126\u20131128","journal-title":"Metabolism"},{"key":"BFncpendmet0844_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1463-1326.2004.00397.x","volume":"7","author":"H de Boer","year":"2005","unstructured":"de Boer H  et al. (2005) Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab 7: 211\u2013215","journal-title":"Diabetes Obes Metab"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0844.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0844","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0844.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:56:11Z","timestamp":1684439771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,3]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BFncpendmet0844"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0844","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,3]]}}}